Medi Assist Healthcare Services Limited has informed stock exchanges about the board approval for a merger between two of its wholly owned subsidiaries. The company filed the disclosure under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Merger Details and Structure

The Board of Directors approved the Scheme of Amalgamation of International Healthcare Management Services Private Limited (IHMS) with Mayfair Consultancy Services India Private Limited (MCSI) on February 06, 2026. Under this arrangement, IHMS will serve as the transferor company while MCSI will be the transferee company.

The board meeting commenced at 02:00 p.m. (IST) and concluded at 05:15 p.m. (IST) on February 06, 2026.

Financial Profile of Merging Entities

Both subsidiaries operate in the healthcare and insurance ecosystem, providing back-office, administrative, data processing, and consultancy services. The financial details as of March 31, 2025 show the scale of operations for both entities.

Strategic Rationale and Benefits

The merger aims to deliver multiple operational and financial benefits. The consolidation will enable seamless access to assets including intangible assets, licenses, and intellectual properties, leading to operational synergies and reduced overheads.

Key anticipated benefits include:

• Streamlined group structure with reduced legal and regulatory compliance requirements
• Cost savings through focused operational efforts and resource rationalization
• Efficient utilization of common resource pools across human resources, administration, finance, and technology functions
• Enhanced cash management and optimized deployment of financial resources for growth opportunities

Transaction Structure and Impact

The merger involves no cash consideration. Upon the scheme becoming effective, the entire share capital of IHMS held by Medi Assist Healthcare Services will be cancelled and extinguished without requiring surrender of shares. The investment in IHMS shares appearing in the parent company's books will stand cancelled automatically.

Since both entities are wholly owned subsidiaries and the parent company is not a direct party to the merger scheme, there will be no change in Medi Assist Healthcare Services' shareholding pattern. The transaction falls under related party provisions but is exempt under Regulation 23(5)(b) of SEBI Listing Regulations and does not require compliance with Section 188 of Companies Act, 2013 as per MCA General Circular No. 30/2014.

Medi assist healthcare Services Limited has officially notified stock exchanges about its upcoming board meeting scheduled for February 6, 2026, to deliberate on the company's third quarter financial performance for fiscal year 2026.

Board Meeting Details

The Board of Directors meeting has been convened under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary agenda involves consideration and approval of unaudited standalone and consolidated financial results for specific reporting periods.

Trading Window Restrictions

In compliance with insider trading regulations, the company has implemented trading restrictions for designated persons. The trading window closure affects company insiders and their immediate relatives during the sensitive period surrounding financial results.

Earnings Conference Call

The company has arranged an earnings conference call to discuss the quarterly financial results with stakeholders. The call will feature key management personnel providing insights into the company's performance.

Call Participants

Conference Call Details

Communication and Compliance

The formal intimation has been submitted to both the National Stock Exchange of India Limited and BSE Limited, ensuring compliance with listing requirements. The notification was signed by Rashmi B V, Company Secretary & Compliance Officer, with ICSI Membership No: A38729, and will be uploaded to the company's official website for public access.